Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Kusiak

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|March 8, 2002
Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protectionWanli Wei, Xiantao Wang, John W Kusiak
Journal of the Neurological Sciences|May 31, 2022
A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?Jin Jun Luo, William Wallace, John W Kusiak
CNS & Neurological Disorders Drug Targets|June 22, 2006
Signaling mechanisms underlying Abeta toxicity: potential therapeutic targets for Alzheimer's diseaseWanli W Smith, Myriam Gorospe, John W Kusiak
Brain : a Journal of Neurology|August 17, 2002
Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosisWanli Wei, Darrell D Norton, Xiantao Wang, et al.
Frontiers in Dental Medicine|February 7, 2025
Perspective: Advancing the science regarding temporomandibular disordersRichard Ohrbach, Alexandre F DaSilva, Mildred C Embree, et al.
The Journal of Cell Biology|April 20, 2005
Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicityWanli W Smith, Darrell D Norton, Myriam Gorospe, et al.
Biochimica Et Biophysica Acta|June 28, 2003
Red cell perturbations by amyloid beta-proteinRajadas Jayakumar, John W Kusiak, Francis J Chrest, et al.
Plos One|March 19, 2013
Enhanced Aβ(1-40) production in endothelial cells stimulated with fibrillar Aβ(1-42)Jayakumar Rajadas, Wenchao Sun, Hai Li, et al.
Frontiers in Digital Health|May 31, 2023
Building the foundation for a modern patient-partnered infrastructure to study temporomandibular disordersLaura Elisabeth Gressler, Terrie Cowley, Marti Velezis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|March 8, 2002
Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protectionWanli Wei, Xiantao Wang, John W Kusiak
Journal of the Neurological Sciences|May 31, 2022
A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?Jin Jun Luo, William Wallace, John W Kusiak
CNS & Neurological Disorders Drug Targets|June 22, 2006
Signaling mechanisms underlying Abeta toxicity: potential therapeutic targets for Alzheimer's diseaseWanli W Smith, Myriam Gorospe, John W Kusiak
Brain : a Journal of Neurology|August 17, 2002
Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosisWanli Wei, Darrell D Norton, Xiantao Wang, et al.
Frontiers in Dental Medicine|February 7, 2025
Perspective: Advancing the science regarding temporomandibular disordersRichard Ohrbach, Alexandre F DaSilva, Mildred C Embree, et al.
The Journal of Cell Biology|April 20, 2005
Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicityWanli W Smith, Darrell D Norton, Myriam Gorospe, et al.
Biochimica Et Biophysica Acta|June 28, 2003
Red cell perturbations by amyloid beta-proteinRajadas Jayakumar, John W Kusiak, Francis J Chrest, et al.
Plos One|March 19, 2013
Enhanced Aβ(1-40) production in endothelial cells stimulated with fibrillar Aβ(1-42)Jayakumar Rajadas, Wenchao Sun, Hai Li, et al.
Frontiers in Digital Health|May 31, 2023
Building the foundation for a modern patient-partnered infrastructure to study temporomandibular disordersLaura Elisabeth Gressler, Terrie Cowley, Marti Velezis, et al.
Pageof 1